Fierce Pharma2h
Bluebird bio receives rival M&A bid worth 50% higher than Carlyle-SK offer
A rival bidder has emerged to acquire struggling gene therapy specialist bluebird bio. | A rival bidder has emerged to ...
Health on MSN6h
FDA Says Ozempic Is No Longer in Shortage—Does That Mean the End of Cheaper Copycat Versions?
Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...
Sanofi’s Easier to Use Hemophilia Drug Approved by US FDA
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval
A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
Semaglutide and Tirzepatide off FDA shortage list: What does this mean for weight loss drug access?
The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs ...
Fierce Pharma2d
Senate confirms Johns Hopkins surgeon Marty Makary to lead FDA amid turbulence at the agency
Despite the uncertainty currently sweeping through the Food and Drug Administration, President Donald Trump’s pick to lead ...